These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1108276)

  • 21. [New treatment possibilities in obstructive respiratory tract diseases].
    Rambauske F
    Wien Med Wochenschr; 1971 Jan; 121(3):36-7. PubMed ID: 5545426
    [No Abstract]   [Full Text] [Related]  

  • 22. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medical treatment of seromucous otitis].
    Renou G; Ketari M; Toutée JP; Benzaken J
    Rev Laryngol Otol Rhinol (Bord); 1989; 110(3):327-8. PubMed ID: 8638061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Further study on the possibility of using carbocysteine in cystic fibrosis].
    Ferraris S; Zannini G
    Minerva Pediatr; 1983 Nov; 35(22):1145-50. PubMed ID: 6369102
    [No Abstract]   [Full Text] [Related]  

  • 25. [Criteria of drug testing in industrial practice, demonstrated by a cough remedy].
    Nesswetha W
    Arzneimittelforschung; 1967 Oct; 17(10):1324-6. PubMed ID: 4885305
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trial with CO-1177: a preliminary report.
    Mbuyamba P
    Int J Clin Pharmacol Res; 1986; 6(2):119-21. PubMed ID: 3522442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chronic-obstructive lung diseases. The treatment of chronic-obstructive lung diseases with transbronchin].
    Haage W
    ZFA (Stuttgart); 1978 Jul; 54(21):1099-102. PubMed ID: 685402
    [No Abstract]   [Full Text] [Related]  

  • 28. [Expectorants in the therapy of respiratory disease].
    Ther Umsch; 1965 Jul; 22(7):392-402. PubMed ID: 5834882
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction].
    Löllgen H; Löllgen-Horres I; von Nieding G
    Fortschr Med; 1976 Aug; 94(24):1276-84. PubMed ID: 786833
    [No Abstract]   [Full Text] [Related]  

  • 30. s-Carboxy-methyl-cysteine syrup in secretory otitis media.
    Taylor PH; Dareshani N
    Br J Clin Pract; 1975 Jul; 29(7):177-8, 180. PubMed ID: 1103927
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic activity of an association of a mucolytic drug and a bronchodilator agent in the treatment of respiratory inflammations].
    Boselli G
    Minerva Med; 1973 Nov; 64(79):4128-37. PubMed ID: 4765427
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 33. [Apropos of 27 patients treated with bisolvomycin].
    Breuil K
    Bord Med; 1971 Sep; 4(9):2469-70. PubMed ID: 5123583
    [No Abstract]   [Full Text] [Related]  

  • 34. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
    Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
    Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK
    Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of S-carboxymethyl-L-cysteine for otitis media with effusion.
    Steventon GB; Mitchell SC
    Ear Nose Throat J; 2006 May; 85(5):296-7. PubMed ID: 16771015
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical experience with a new mucus disolving agent (Bisolvon) for the therapy of whooping cough and diseases of the respiratory tract].
    Ertogan F
    Kinderarztl Prax; 1967 Apr; 35(4):141-6. PubMed ID: 5594869
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative evaluation of the effectiveness of lasolvan and mucodine in chronic nonspecific lung diseases].
    Solopov VN; Kolganova NA
    Sov Med; 1988; (5):69-72. PubMed ID: 3062806
    [No Abstract]   [Full Text] [Related]  

  • 40. [Parenteral treatment of respiratory tract diseases with Bisolvone].
    Stahlmann W; Siehoff F; Mathey HG; Schilling T; Weis H
    Dtsch Med J; 1966 Aug; 17(16):478-80. PubMed ID: 5925468
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.